sglt2

SGLT-2 Inhibitors in the Treatment of Type 2 Diabetes: Methodology and Monitoring Impact

  In this CME offering presented by the Primary Care Network and Diabetes Series Live, Drs. Richard Beaser, Associate Professor of Medicine and Harvard Medical School and Nuha El Sayed, Director of International Programs at Joslin Diabetes Center introduce and educate viewers on a relatively new class of drugs to combat Type II Diabetes; the […]

Continue Reading
screen-shot-2016-11-03-at-3-58-01-pm

The Evolving Genesis of Obesity

Over the past many years or decades, people believed that obesity was caused by a misbalance of calories: obese patients consume more calories that they expend. While this is true in many cases, it is not the complete picture. Recent research is discovering a whole host of causes that contribute to obesity and it is […]

Continue Reading
chf1

Congestive Heart Failure 2016 Update

Our understanding of congestion heart failure has been rapidly evolving over the past decade.  Heart failure is a leading cause of mortality globally and in the US. It is the final end-point of various cardiac diseases.  When the cardiac muscles fail, hypertrophy of the cardiac muscle cells is commonly observed. This hypertrophy of cardiomyoctes is […]

Continue Reading